Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-11-13 4:46 pm Purchase | 13D | ACUTUS MED INC AFIB | Flynn James E | 9,677,857 9.22% | 32,892 (+0.34%) | View |
| 2023-02-13 2:49 pm Sale | 13G | ACUTUS MED INC AFIB | Capital World Investors | 797,523 2.8% | -802,477 (-50.15%) | View |
| 2022-07-05 5:15 pm Purchase | 13D | ACUTUS MED INC AFIB | Flynn James E | 9,644,965 9.4% | 3,780,451 (+64.46%) | View |
| 2022-04-27 3:49 pm Purchase | 13D | ACUTUS MED INC AFIB | Flynn James E | 5,864,514 9.4% | 11,590 (+0.20%) | View |
| 2022-02-11 6:04 pm Unchanged | 13G | ACUTUS MED INC AFIB | Advent Life Sciences LLP | 1,619,371 5.8% | 0 (Unchanged) | View |
| 2022-02-11 4:04 pm Sale | 13G | ACUTUS MED INC AFIB | Kerrisdale Advisers LLC | 0 0% | -1,750,920 (Position Closed) | View |
| 2022-02-11 2:48 pm Purchase | 13G | ACUTUS MED INC AFIB | Capital World Investors | 1,600,000 5.7% | 1,600,000 (New Position) | View |
| 2021-11-18 4:56 pm Sale | 13D | ACUTUS MED INC AFIB | ORBIMED ADVISORS LLC | 2,648,386 9.5% | -4,233,567 (-61.52%) | View |
| 2021-08-31 4:52 pm Purchase | 13D | ACUTUS MED INC AFIB | ORBIMED ADVISORS LLC | 6,881,953 7.7% | 1,071,428 (+18.44%) | View |
| 2021-08-26 4:20 pm Purchase | 13D | ACUTUS MED INC AFIB | Flynn James E | 5,852,924 9.5% | 345 (+0.01%) | View |
| 2021-07-21 5:13 pm Purchase | 13D | ACUTUS MED INC AFIB | Flynn James E | 5,852,579 17.19% | 1,071,428 (+22.41%) | View |
| 2021-07-21 09:05 am Purchase | 13G | ACUTUS MED INC AFIB | Kerrisdale Advisers LLC | 1,750,920 5.2% | 1,750,920 (New Position) | View |
| 2021-07-13 9:24 pm Unchanged | 13D | ACUTUS MED INC AFIB | ORBIMED ADVISORS LLC | 5,810,525 20.4% | 0 (Unchanged) | View |
| 2021-07-13 4:52 pm Purchase | 13D | ACUTUS MED INC AFIB | Flynn James E | 4,781,151 16.75% | 5,235 (+0.11%) | View |
| 2021-02-11 4:15 pm Purchase | 13G | ACUTUS MED INC AFIB | Zahir Fares | 1,166,690 4.2% | 1,166,690 (New Position) | View |
| 2021-02-10 3:46 pm Purchase | 13G | ACUTUS MED INC AFIB | Advent Life Sciences LLP | 1,619,371 5.8% | 1,619,371 (New Position) | View |
| 2020-08-20 4:17 pm Purchase | 13D | ACUTUS MED INC AFIB | Flynn James E | 4,775,916 17.14% | 4,775,916 (New Position) | View |
| 2020-08-18 4:31 pm Purchase | 13D | ACUTUS MED INC AFIB | ORBIMED ADVISORS LLC | 5,810,525 20.9% | 5,810,525 (New Position) | View |